Immunobiologists Robert Schreiber, PhD, (left) and Hussein Sultan, PhD, of Washington University School of Medicine in St. Louis, found that a subset of immune cells
The U.S. Food and Drug Administration has scolded Bristol Myers Squibb for making false and misleading claims about a lung cancer treatment on a website
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a protein receptor on T immune cells that prevents the cells from killing other cells, such as cancer cells.
In 2022, IDRx raised $122m in Series A financing and licensed two TKI inhibitors – IDRX-42 from Merck KGaA, and IDRX-73 from Blueprint Medicines. Image
The director general of the World Health Organization announced Wednesday that he will convene a panel of experts to advise him on whether the expanding
Sales for the drug are predictably up compared to last year – but not by the anticipated margin. Image credit: Shutterstock / KK Stock. Novo
RRP is a rare condition characterised by the growth of benign tumours on and around the vocal cords. Credit: Andrey_Popov via Shutterstock. US-based cell and
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After
Novo Nordisk is pulling its regulatory submissions to expand the use of its obesity drug Wegovy for a common type of heart failure, saying that
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We recap